166 related articles for article (PubMed ID: 28285969)
1. Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
Tan B; Li Y; Shi X; Fan L; Zhao Q; Liu Y; Tan M; Liu Q; Jia N
Pathol Res Pract; 2017 May; 213(5):435-440. PubMed ID: 28285969
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of increased guanine nucleotide exchange factor Vav3 expression in human gastric cancer.
Lin KY; Wang LH; Hseu YC; Fang CL; Yang HL; Kumar KJ; Tai C; Uen YH
Mol Cancer Res; 2012 Jun; 10(6):750-9. PubMed ID: 22544459
[TBL] [Abstract][Full Text] [Related]
4. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
Li L; Zhang S; Lin H; Lin JY
Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
Tan B; Li Y; Wang C; Tan M; Fan L; Zhao Q; Wang D; Jia N
Br J Biomed Sci; 2017 Jul; 74(3):133-137. PubMed ID: 28513273
[TBL] [Abstract][Full Text] [Related]
6. Upregulated Vav2 in gastric cancer tissues promotes tumor invasion and metastasis.
Tan BB; Li Y; Fan LQ; Zhao Q; Liu QW; Liu Y; Wang D; Jia N
Tumour Biol; 2017 May; 39(5):1010428317698392. PubMed ID: 28459214
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.
Tan B; Li Y; Zhao Q; Fan L; Wang D; Liu Y
Tumour Biol; 2014 Feb; 35(2):1481-8. PubMed ID: 24072493
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
11. Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Miyagi Y
Gastric Cancer; 2006; 9(2):106-13. PubMed ID: 16767366
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
13. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomartker for invasion and its impact on survival.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
Cancer; 2001 May; 91(9):1739-44. PubMed ID: 11335899
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients.
Łukaszewicz-Zając M; Mroczko B; Guzińska-Ustymowicz K; Pryczynicz A; Gryko M; Kemona A; Kędra B; Szmitkowski M
Adv Med Sci; 2013; 58(2):235-43. PubMed ID: 24384769
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Zhang Q; Wang P; Shao M; Chen SW; Xu ZF; Xu F; Yang ZY; Liu BY; Gu QL; Zhang WJ; Li Y
Tumori; 2015; 101(5):566-71. PubMed ID: 26350198
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Zhang Y; Qin L; Ma X; Wang Y; Wu Y; Jiang J
Dis Markers; 2020; 2020():8831466. PubMed ID: 33005257
[TBL] [Abstract][Full Text] [Related]
19. MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Yao Z; Yuan T; Wang H; Yao S; Zhao Y; Liu Y; Jin S; Chu J; Xu Y; Zhou W; Yang S; Liu Y
Tumour Biol; 2017 Jun; 39(6):1010428317700411. PubMed ID: 28621235
[TBL] [Abstract][Full Text] [Related]
20. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
